Band 11q13 is nonrandomly rearranged in hibernomas.

Hibernomas are characterized by homozygous deletions in the multiple endocrine neoplasia type I region. Metaphase fluorescence in situ hybridization reveals complex rearrangements not detected by conventional cytogenetics. Am J Pathol (1999) 0.88

Hibernoma--two patients with a rare lipoid soft-tissue tumour. BMC Med Imaging (2015) 0.82

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science (1999) 83.27

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol (1999) 12.42

Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet (2000) 8.58

All-trans-retinoic acid in acute promyelocytic leukemia. N Engl J Med (1997) 4.79

Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study. Cancer Res (2001) 3.66

Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg (1999) 3.56

Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol (2000) 3.42

Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol (1990) 3.19

Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics. Proc Natl Acad Sci U S A (2001) 3.01

The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. Ann Oncol (1999) 2.84

Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg (1996) 2.68

ras oncogene activation and occupational exposures in acute myeloid leukemia. J Natl Cancer Inst (1992) 2.54

The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Histopathology (2000) 2.51

The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting--Airlie House, Virginia, November, 1997. Hematol J (2000) 2.34

Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics. Cancer Res (1998) 2.33

Bilateral trephine bone marrow biopsies in lymphoma and other neoplastic diseases. Ann Intern Med (1975) 2.25

Controversies in transfusion medicine. Prophylactic platelet transfusion therapy: pro. Transfusion (1992) 2.21

Prolonged subcutaneous administration of recombinant alpha 2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myelogenous leukemia: effect on remission duration and survival: Cancer and Leukemia Group B study 8583. Blood (1993) 2.16

Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial. Ann Surg (1993) 2.08

Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol (2001) 2.06

Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11. Cancer Res (1996) 1.99

Prospective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia Group B experience. Blood (1999) 1.85

Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Lancet (1996) 1.81

The partial tandem duplication of ALL1 (MLL) is consistently generated by Alu-mediated homologous recombination in acute myeloid leukemia. Proc Natl Acad Sci U S A (1998) 1.79

ALL-1 partial duplication in acute leukemia. Proc Natl Acad Sci U S A (1994) 1.74

Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor: evidence for its fusion with MLL in acute myeloid leukemia. Proc Natl Acad Sci U S A (2000) 1.69

The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Mod Pathol (2000) 1.68

Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B. Blood (1981) 1.68

Metastatic patterns in soft-tissue sarcomas. Arch Surg (1983) 1.66

Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. Cancer Res (1986) 1.55

Desmoid tumour: a pleomorphic lesion. Eur J Surg Oncol (1999) 1.54

Molecular rearrangement of the ALL-1 gene in acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocations. Cancer Res (1994) 1.54

Morphologic and cytochemical characteristics of acute promyelocytic leukemia. Am J Hematol (1989) 1.54

Clinical importance of cytogenetics in acute myeloid leukaemia. Best Pract Res Clin Haematol (2001) 1.52

ALL-1 tandem duplication in acute myeloid leukemia with a normal karyotype involves homologous recombination between Alu elements. Cancer Res (1994) 1.52

DNMT3A mutations and response to the hypomethylating agent decitabine in acute myeloid leukemia. Leukemia (2011) 1.49

Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia. Blood (1996) 1.49

BAALC, the human member of a novel mammalian neuroectoderm gene lineage, is implicated in hematopoiesis and acute leukemia. Proc Natl Acad Sci U S A (2001) 1.48

Leiomyosarcoma of the inferior vena cava: a clinicopathologic review and report of three cases. J Surg Oncol (1997) 1.46

Multidrug resistance in acute myeloid leukemia. J Natl Cancer Inst (1991) 1.45

Desmoid tumors in patients with familial adenomatous polyposis. Cancer (1994) 1.44

What is a surgical oncologist? Ann Surg Oncol (1994) 1.40

Autologous bone marrow transplantation in non-Hodgkin's lymphoma: monoclonal antibodies plus complement for ex vivo marrow treatment. Am J Med (1988) 1.39

Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine. Blood (2001) 1.38

Survival in metastatic ocular melanoma. Cancer (1983) 1.37

Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461. J Clin Oncol (1997) 1.36

Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered. J Clin Oncol (1999) 1.36

Report of the Committee on Chromosome Rearrangements in Neoplasia and on Fragile Sites. Cytogenet Cell Genet (1985) 1.36

Intravenous leiomyomatosis with cardiac extension: tumor thrombectomy through an abdominal approach. J Vasc Surg (2000) 1.35

A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111. Blood (1998) 1.35

All patients with acute nonlymphocytic leukemia may have a chromosomal defect. N Engl J Med (1981) 1.29

Incidence cytology, and histopathology of non-Hodgkin's lymphomas in the bone marrow. Cancer (1974) 1.27

Prognostic value of lymph node dissection in malignant melanoma. Arch Surg (1980) 1.24

Adult patients with de novo acute myeloid leukemia and t(9; 11)(p22; q23) have a superior outcome to patients with other translocations involving band 11q23: a cancer and leukemia group B study. Blood (1997) 1.23

Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia. Blood (1994) 1.22

Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B Study (8762). Blood (1992) 1.21

Blast crisis as an initial or terminal manifestation of chronic myeloid leukemia. A study of 28 patients. Am J Med (1976) 1.21

Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: a Cancer and Leukemia Group B Study. J Clin Oncol (2001) 1.20

Nodular lymphoma: bone marrow and blood manifestations. Cancer (1975) 1.20

Cytogenetic findings in liposarcoma correlate with histopathologic subtypes. Cancer (1992) 1.18

There are differences in cytogenetic abnormalities among histologic subtypes of the non-Hodgkin's lymphomas. Blood (1985) 1.18

An altered 11-kilobase transcript in leukemic cell lines with the t(4;11)(q21;q23) chromosome translocation. Cancer Res (1992) 1.18

Cytogenetic profile of 109 lipomas. Cancer Res (1991) 1.18

A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemia. N Engl J Med (1981) 1.17

B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease. J Clin Invest (1973) 1.17

Desmoid tumors and their management. Am J Surg (1985) 1.15

Report of the committee on structural chromosome changes in neoplasia. Cytogenet Cell Genet (1987) 1.15

Nonrandom chromosome abnormalities in lymphoma. Cancer Res (1983) 1.14

Prognostic significance of lymph node metastasis and bone, major vessel, or nerve involvement in adults with high-grade soft tissue sarcomas. Cancer (1988) 1.13

Malignant soft tissue tumors of nerve sheath origin. J Surg Oncol (1984) 1.13

Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia. Blood (1986) 1.12

Complications and outcome of external hemipelvectomy in the management of pelvic tumors. Ann Surg Oncol (1996) 1.12

Detection of minimal residual disease in patients with AML1/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay. Leukemia (1998) 1.11

Increased anti-leukemic activity of decitabine via AR-42-induced upregulation of miR-29b: a novel epigenetic-targeting approach in acute myeloid leukemia. Leukemia (2012) 1.11

Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure. Semin Oncol (1992) 1.11

Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22). Blood (1997) 1.10

Liposarcomas: prognosis and management. J Surg Oncol (1980) 1.09

Clinical significance of cytogenetics in acute myeloid leukemia. Semin Oncol (1997) 1.08

Secondary cytogenetic changes in acute promyelocytic leukemia--prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B study. J Clin Oncol (1997) 1.07

Curative radiotherapy for laparotomy-staged IA, IIA, IIIA Hodgkin's disease: an evaluation of the gains achieved with radical radiotherapy. Int J Radiat Oncol Biol Phys (1990) 1.06

Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720. Leukemia (2011) 1.05

Prognostic significance of mediastinal involvement in Hodgkin's disease treated with curative radiotherapy. Cancer (1980) 1.04

Anorectal melanoma: clinical features, recurrence and patient survival. Int Surg (1981) 1.04

Banded chromosome analysis in patients with treatment-associated acute nonlymphocytic leukemia. Cancer Genet Cytogenet (1984) 1.03

High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361). Blood (2001) 1.03

Richter hernia of the stomach. J Surg Oncol (1998) 1.02

Pyomyositis: a differential diagnosis from sarcoma. J Surg Oncol (1985) 1.02

The surgical treatment and outcome of soft-tissue sarcoma. Arch Surg (1981) 1.01

Novel methylation targets in de novo acute myeloid leukemia with prevalence of chromosome 11 loci. Blood (2001) 1.01

Distant skin and soft tissue metastases from sarcomas. J Surg Oncol (1998) 1.01

Gastrointestinal metastases from malignant melanoma. Surg Oncol (1995) 1.01

Symptomatic gastrointestinal metastases from malignant melanoma. Cancer (1981) 1.00

B and T cell lymphomas. Analysis of blood and lymph nodes in 87 patients. Am J Med (1975) 1.00

Intraoperative photodynamic therapy for retroperitoneal sarcomas. Cancer (1988) 1.00

Four new recurring translocations in non-Hodgkin lymphoma. Blood (1989) 1.00

Treatment of unknown primary melanoma. Cancer (1991) 0.99

Clinical utility of lymphocyte surface markers combined with the Lukes-Collins histologic classification in adult lymphoma. N Engl J Med (1979) 0.99

Prognostic significance of lymphocyte surface markers in adult non-Hodgkin's malignant lymphoma. Lancet (1976) 0.99

Management of retroperitoneal sarcomas and patient survival. Am J Surg (1985) 0.99

Translocation 4; 11 in acute lymphoblastic leukemia: clinical characteristics and prognostic significance. Blood (1982) 0.99